Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

Affiliations

• ¹ Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany. [email protected].
• ² Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany.
• ³ Department of Radiotherapy and Radiation Oncology, University Hospital Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
• ⁴ PREFERE Project Management, German Cancer Society, Berlin, Germany.
• ⁵ Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁶ Institute of Pathology, University Hospital Bonn, Bonn, Germany.
• ⁷ Department of Clinical Epidemiology and Applied Biostatistics, University Hospital Tübingen, Tübingen, Germany.
• ⁸ Department of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Mainz, Germany.
• ⁹ Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany.
• ¹⁰ Department of Urology, Klinikum Leverkusen, Leverkusen, Germany.
• ¹¹ Center for Urology, Lübeck, Germany.
• ¹² Department of Urology, Klinikum Lippe Detmold, Detmold, Germany.
• ¹³ Department of Urology, Vinzenzkrankenhaus, Hannover, Germany.
• ¹⁴ Department of Urology, University Hospital Homburg/Saar, Homburg, Germany.